Great Diamond Partners, LLC Novo Nordisk A S Transaction History

Great Diamond Partners, LLC

$387 Million
Q3 2024

A detailed history of Great Diamond Partners, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Great Diamond Partners, LLC holds 30,261 shares of NVO stock, worth $2.57 Million. This represents 0.93% of its overall portfolio holdings.

Number of Shares

30,261

Previous 36,540 17.18%

Holding current value

$2.57 Million

Previous $5.22 Million 30.91%

% of portfolio

0.93%

Previous 1.24%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$119.07 - $145.42 $747,640 - $913,092	-6,279 Reduced 17.18%	30,261 $3.6 Million
Q2 2024 Jul 29, 2024	SELL	$122.71 - $146.91 $11,780 - $14,103	-96 Reduced 0.26%	36,540 $5.22 Million
Q1 2024 May 08, 2024	BUY	$102.11 - $135.92 $387,201 - $515,408	3,792 Added 11.55%	36,636 $4.7 Million
Q4 2023 Feb 07, 2024	SELL	$87.78 - $105.45 $64,254 - $77,189	-732 Reduced 2.18%	32,844 $3.4 Million
Q3 2023 Oct 19, 2023	BUY	$90.94 - $199.54 $1.54 Million - $3.37 Million	16,909 Added 101.45%	33,576 $3.05 Million
Q2 2023 Jul 17, 2023	BUY	$155.98 - $172.65 $1.08 Million - $1.19 Million	6,916 Added 70.93%	16,667 $2.7 Million
Q1 2023 May 04, 2023	SELL	$132.34 - $159.14 $100,843 - $121,264	-762 Reduced 7.25%	9,751 $1.55 Million
Q4 2022 Feb 01, 2023	BUY	$102.55 - $135.33 $40,199 - $53,049	392 Added 3.87%	10,513 $1.42 Million
Q3 2022 Oct 24, 2022	BUY	$95.28 - $116.93 $496,885 - $609,789	5,215 Added 106.3%	10,121 $1.01 Million
Q2 2022 Jul 26, 2022	BUY	$103.24 - $121.81 $31,901 - $37,639	309 Added 6.72%	4,906 $546,000
Q1 2022 May 05, 2022	BUY	$93.1 - $112.54 $166,835 - $201,671	1,792 Added 63.89%	4,597 $510,000
Q4 2021 Jan 26, 2022	BUY	$95.88 - $117.08 $10,450 - $12,761	109 Added 4.04%	2,805 $314,000
Q3 2021 Oct 21, 2021	BUY	$84.42 - $106.62 $24,566 - $31,026	291 Added 12.1%	2,696 $258,000
Q2 2021 Jul 26, 2021	BUY	$67.66 - $84.76 $162,722 - $203,847	2,405 New	2,405 $201,000
Q2 2020 Aug 04, 2020	SELL	$58.54 - $67.94 $364,704 - $423,266	-6,230 Closed	0 $0
Q1 2020 May 01, 2020	SELL	$49.46 - $64.78 $89,967 - $117,834	-1,819 Reduced 22.6%	6,230 $375,000
Q4 2019 Feb 07, 2020	BUY	$49.86 - $58.26 $401,323 - $468,934	8,049 New	8,049 $465,000

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $192B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Diamond Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Diamond Partners, LLC with notifications on news.

Account

Great Diamond Partners, LLC Novo Nordisk A S Transaction History